Voloridge Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Voloridge Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.04M	Sell	83,854 -116,452	-58%	-$3.98M	0.01%	612
2026 Q1	$6.62M	Sell	200,306 -47,369	-19%	-$2.01M	0.03%	615
2025 Q4	$11.5M	Sell	247,675 -1,798	-0.7%	-$75.2K	0.04%	543
2025 Q3	$8.73M	Buy	249,473 +223,329	+854%	+$7.76M	0.03%	578
2025 Q2	$773K	Buy	+26,144	New	+$746K	﹤0.01%	1047
2024 Q4	–	Sell	-15,131	Closed	-$585K	–	1210
2024 Q3	$585K	Buy	+15,131	New	+$540K	﹤0.01%	1070
2023 Q4	–	Sell	-29,922	Closed	-$669K	–	1214
2023 Q3	$669K	Sell	29,922 -76,041	-72%	-$1.73M	﹤0.01%	1166
2023 Q2	$2.28M	Sell	105,963 -18,178	-15%	-$413K	0.01%	946
2023 Q1	$2.98M	Buy	+124,141	New	+$3.29M	0.01%	847
2020 Q4	–	Sell	-37,244	Closed	-$775K	–	1353
2020 Q3	$775K	Buy	+37,244	New	+$672K	0.01%	1008
2020 Q2	–	Sell	-18,773	Closed	-$307K	–	1291
2020 Q1	$307K	Buy	18,773 +4,597	+32%	+$94.9K	0.01%	861
2019 Q4	$292K	Buy	+14,176	New	+$236K	0.01%	940
2019 Q2	–	Sell	-21,212	Closed	-$321K	–	798
2019 Q1	$321K	Buy	+21,212	New	+$340K	0.01%	788

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Voloridge Investment Management's COLL Position: Q2 2026 in Review

Voloridge Investment Management reduced its Collegium Pharmaceutical (COLL) stake by 58% in Q2 2026, selling an estimated $3.98M and leaving 83,854 shares worth $3.04M. The position accounts for 0.01% of the portfolio, ranked #612.

Voloridge Investment Management first reported a position in COLL in Q1 2019 and has held it in 13 quarters since. The position peaked at $11.5M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Voloridge Investment Management held 83,854 shares of Collegium Pharmaceutical worth $3.04M as of Q2 2026.
Voloridge Investment Management sold 116,452 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.98M.
Collegium Pharmaceutical made up 0.01% of Voloridge Investment Management's portfolio in Q2 2026, its #612 holding.
Voloridge Investment Management first reported a position in Collegium Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
Voloridge Investment Management's Collegium Pharmaceutical position peaked at $11.5M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.